DocuSign (NASDAQ:DOCU) Announces Earnings Results, Beats Expectations By $0.17 EPS

DocuSign (NASDAQ:DOCUGet Free Report) announced its earnings results on Thursday. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.17, Briefing.com reports. The business had revenue of $736.03 million during the quarter, compared to analyst estimates of $727.20 million. DocuSign had a net margin of 3.81% and a return on equity of 15.44%. DocuSign’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.09 earnings per share. DocuSign updated its FY 2025 guidance to EPS and its Q3 2025 guidance to EPS.

DocuSign Stock Up 4.0 %

Shares of NASDAQ DOCU opened at $59.19 on Friday. The company has a market cap of $12.12 billion, a price-to-earnings ratio of 113.83, a PEG ratio of 9.74 and a beta of 0.93. DocuSign has a 52 week low of $38.11 and a 52 week high of $64.76. The firm’s fifty day moving average is $55.44 and its 200 day moving average is $55.86.

Insider Transactions at DocuSign

In other news, insider James P. Shaughnessy sold 1,800 shares of DocuSign stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $50.98, for a total transaction of $91,764.00. Following the sale, the insider now owns 35,703 shares of the company’s stock, valued at approximately $1,820,138.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Daniel D. Springer sold 287,052 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $53.78, for a total value of $15,437,656.56. Following the completion of the transaction, the director now owns 923,445 shares of the company’s stock, valued at approximately $49,662,872.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider James P. Shaughnessy sold 1,800 shares of the firm’s stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $50.98, for a total value of $91,764.00. Following the completion of the transaction, the insider now owns 35,703 shares of the company’s stock, valued at approximately $1,820,138.94. The disclosure for this sale can be found here. In the last three months, insiders have sold 482,418 shares of company stock worth $25,524,100. 1.66% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Morgan Stanley cut their target price on shares of DocuSign from $65.00 to $62.00 and set an “equal weight” rating for the company in a research report on Friday, June 7th. Royal Bank of Canada upped their price objective on DocuSign from $52.00 to $57.00 and gave the stock a “sector perform” rating in a report on Friday. Needham & Company LLC reissued a “hold” rating on shares of DocuSign in a report on Friday. Robert W. Baird boosted their target price on DocuSign from $55.00 to $59.00 and gave the stock a “neutral” rating in a research report on Friday. Finally, JMP Securities reiterated a “market outperform” rating and set a $84.00 price target on shares of DocuSign in a research report on Thursday. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, DocuSign has an average rating of “Hold” and an average target price of $61.45.

Read Our Latest Stock Report on DOCU

About DocuSign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Earnings History for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.